Effects of teriparatide versus alendronate for treatment of postmenopausal osteoporosis: A meta-analysis of randomized controlled trials

OBJECTIVES: Osteoporosis remains a clinical challenge. Teriparatide is an anabolic drug and alendronate is an antiresorptive agent; both are used in the treatment of osteoporosis. Comprehensive reviews investigating the comparative safety and efficacy of teriparatide versus alendronate are scarce. T...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Medicine (Baltimore)
Prif Awduron: Wang, Ya-Kang, Qin, Si-Qing, Ma, Tao, Song, Wei, Jiang, Ren-Qi, Guo, Jian-Bin, Li, Kun, Zhang, Yu-Min
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Wolters Kluwer Health 2017
Pynciau:
7400
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5457876/
https://ncbi.nlm.nih.gov/pubmed/28538396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000006970
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg